Quiz

Genetics and Genomics

Precision Medicine for Your Practice: Genetic Testing in Pediatric Neurology

Developed in collaboration with

Learning Objectives
1. Identify scenarios in which there is further value added by molecular diagnosis
2. Evaluate the appropriateness of different genetic/genomic tests for clinical context
3. Evaluate when consulting a genetic expert can be helpful

0.5 Credit CME

Clinical Education from The Jackson Laboratory

Activity Information and Disclosures

Precision Medicine

Module Take Quiz

Pediatric neurology providers and patients have more options than ever before for genetic testing. Evidence is growing for the utility of genetic testing for a range of conditions for the purpose of diagnosis and optimizing treatment. While genetic testing can be a powerful tool in certain situations, not all genetic testing is the same. Broader tests assess more genes and increase the possibility of a diagnosis, but also confer specific benefits, limitations, and challenges in results interpretation and counseling.

Precision Medicine for Your Practice is a series of short (20-30 min), online modules covering specific topics in genomics and precision medicine. In this module, Genetic Testing in Pediatric Neurology, participants will learn the benefits and limitations of genetic testing for pediatric neurological conditions. This online module will include five parts: overview information via an animated video; practice cases to facilitate learning-by-doing; and "dig deeper," logistics, and additional resources for those who are interested in more detail.

Take Quiz

Activity Information

AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships.

If applicable, all relevant financial relationships have been mitigated.

Credit Renewal Date: September 8, 2022

Target Audience

This activity is designed to meet the educational needs of practicing physicians who work with children with neurologic conditions.

Accreditation

The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Hardware/Software Requirements

Audio speakers or headphones

Screen resolution of 800X600 or higher

Adobe Reader 5.0 or higher

Check the supported browsers.

Should you have technical questions or questions regarding the content of the activity, please email Clinical and Continuing Education at the Jackson Laboratory.

Multimedia Contributors

• Emily Edelman, MS, CGC, Director, Clinical Education, The Jackson Laboratory

• Therese Ingram, MA, Associate Director and Senior Instructional Designer/Technologist, Clinical Education, The Jackson Laboratory

• Laura Nicholson, MD, PhD, Director of Research, Graduate Medical Education (GME), Scripps Health

• Kate Reed, MPH, ScM, CGC, Director, Precision Oncology Education, Clinical Education, The Jackson Laboratory

• Linda Steinmark, MS, CGC, Project Manager, Clinical Education, The Jackson Laboratory

Disclaimer

All information in Precision Medicine for Your Practice is provided for educational purposes only. This information is not a substitute for clinical guidance or the consultation of a medical professional. Always seek the advice of a qualified health professional with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read in Precision Medicine for Your Practice. Reliance on any information in Precision Medicine for Your Practice is solely at your own risk. The Jackson Laboratory does not endorse or recommend any specific procedures, tests, products, services, health professionals or other information that may be found in Precision Medicine for Your Practice.

References:

Baker E, Jeste S. Diagnosis and Management of Autism Spectrum Disorder in the Era of Genomics Rare Disorders Can Pave the Way for Targeted Treatments. Pediatr Clin North Am. 2015;62:607–618.Google Scholar

Bello L, Pegoraro E. Genetic diagnosis as a tool for personalized treatment of Duchenne muscular dystrophy. Acta Myol. 2016;35(3):122–127.Google Scholar

Bioethics Committee, Committee on Genetics, American College of Medical Genetics and Genomics Social, Ethical, and Legal Committee (2013). Ethical and Policy Issues in Genetic Testing and Screening of Children. Pediatrics. 2013;131(3):620–622.Google Scholar

Bird TD. Approaches to the Patient with Neurogenetic Disease. Clin Lab Med. 2010;30:785–793.Google Scholar

Bush LW, Bartoshesky LE, David KL, Wilfond B, Williams JL, Holm IA; ACMG SELI committee. Pediatric clinical exome/genome sequencing and the engagement process: encouraging active conversation with the older child and adolescent: points to consider-a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018 Jul;20(7):692–694.Google Scholar

Deignan JL, Chung WK, Kearney HM, Monaghan KG, Rehder CW, Chao EC; ACMG Laboratory Quality Assurance Committee. Points to consider in the reevaluation and reanalysis of genomic test results: a statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2019 Jun;21(6):1267–1270.Google Scholar

Demarest ST, Brooks-Kayal A. From molecules to medicines: the dawn of targeted therapies for genetic epilepsies. Nat Rev Neurol. 2018;14(12):735–745.Google Scholar

Dowling JJ, D Gonorazky H, Cohn RD, Campbell C. Treating pediatric neuromuscular disorders: The future is now. Am J Med Genet A. 2018;176(4):804–841.Google Scholar

Finucane B, Abrams L, Cronister A, Archibald AD, Bennett RL, McConkie-Rosell A. Genetic Counseling and Testing for FMR1 Gene Mutations: Practice Guidelines of the National Society of Genetic Counselors. J Genet Couns. 2012;21(6):752–760.Google Scholar

10.

Fogel BL. Genetic and genomic testing for neurologic disease in clinical practice. Handb Clin Neurol. 2018;147:11–22.Google Scholar

11.

Fogel BL, Saty Satya-Murti, Cohen BH. Clinical exome sequencing in neurologic disease. Neurol Clin Pr. 2016;6:164–176.Google Scholar

12.

Han JY, Lee IG. Genetic tests by next-generation sequencing in children with developmental delay and/or intellectual disability. Clin Exp Pediatr. 2020 Jun;63(6):195–202.Google Scholar

13.

Huang Y, Yu S, Wu Z TB. Genetics of hereditary neurological disorders in children. Transl Pediatr. 2014;3(2):108–119.Google Scholar

14.

Hyman SL, Levy SE, Myers SM.. Executive Summary: Identification, Evaluation, and Management of Children With Autism Spectrum Disorder Pediatrics. 2020 Jan;145(1):e20193448.Google Scholar

15.

Kang PB. Ethical issues in neurogenetic disorders. Ethical Leg Issues Neurol. 2013;118:265–276.Google Scholar

16.

Kaufmann WE. Neurogenetics in Child Neurology: Redefining a Discipline in the Twenty-first Century. Curr Neurol Neurosci Rep. 2016;16:103.Google Scholar

17.

Kiely B, Vettam S, Adesman A. Utilization of genetic testing among children with developmental disabilities in the United States. Appl Clin Genet. 2016;9:93–100.Google Scholar

18.

Malinowski J, Miller DT, Demmer L, Gannon J, Pereira EM, Schroeder MC, Scheuner MT, Tsai AC, Hickey SE, Shen J; ACMG Professional Practice and Guidelines Committee. Systematic evidence-based review: outcomes from exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability. Genet Med. 2020 Jun;22(6):986–1004.Google Scholar

19.

Manickam K, McClain MR, Demmer LA, Biswas S, Kearney HM, Malinowski J, Massingham LJ, Miller D, Yu TW, Hisama FM; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Nov;23(11):2029–2037.Google Scholar

20.

Manning M, Hudgins L; American College of Medical Genetics and Genomics (ACMG) Professional Practice and Guidelines Committee. Addendum: Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities (ACMG). Genet Med. 2020 Dec;22(12):2126.Google Scholar

21.

Miller DT, Lee K, Chung WK, Gordon AS, Herman GE, Klein TE, Stewart DR, Amendola LM, Adelman K, Bale SJ, Gollob MH, Harrison SM, Hershberger RE, McKelvey K, Richards CS, Vlangos CN, Watson MS, Martin CL; ACMG Secondary Findings Working Group. ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Aug;23(8):1381–1390.Google Scholar

22.

Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, Chung WK, Gollob MH, Harrison SM, Herman GE, Hershberger RE, Klein TE, McKelvey K, Richards CS, Vlangos CN, Stewart DR, Watson MS, Martin CL; ACMG Secondary Findings Working Group. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 Aug;23(8):1391–1398.Google Scholar

23.

Narayanan V. Genetics and Child Neurology: What Every Trainee/Resident Should Know. Semin Pediatr Neurol. 2011;18:81–84.Google Scholar

24.

Neubauer BA, Lemke JR. From Genetics to Genomics: A Short Introduction for Pediatric Neurologists. Neuropediatrics. 2016;47:5–11.Google Scholar

25.

Ream MA, Patel AD. Obtaining genetic testing in pediatric epilepsy. Epilepsia. 2015;56(10):1505–1514.Google Scholar

26.

Savatt JM, Myers SM. Genetic Testing in Neurodevelopmental Disorders. Front Pediatr. 2021 Feb19 ;9:526779.Google Scholar

27.

Silveira-Moriyama L, Paciorkowski AR. Genetic Diagnostics for Neurologists. Contin Lifelong Learn Neurol. 2018;24(1):18–36.Google Scholar

28.

Sisodiya SM. Genetic screening and diagnosis in epilepsy? Curr Opin Neurol. 2015;28(2):136–142.Google Scholar

29.

Spector E, Behlmann A, Kronquist K, Rose NC, Lyon E, Reddi HV; ACMG Laboratory Quality Assurance Committee. Laboratory testing for fragile X, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2021 May;23(5):799–812.Google Scholar

30.

Vento JM. Family History: A Guide for Neurologists in the Age of Genomic Medicine. Semin Pediatr Neurol. 2012;19:160–166.Google Scholar

31.

Waggoner D, Wain KE, Dubuc AM, Conlin L, Hickey SE, Lamb AN, Martin CL, Morton CC, Rasmussen K, Schuette JL, Schwartz S, Miller DT; ACMG Professional Practice and Guidelines Committee. Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018 Oct;20(10):1105–1113.Google Scholar

Precision Medicine for Your Practice: Genetic Testing in Pediatric Neurology

Please finish the activity before taking the quiz.

AMA Membership provides:

Sign in to access

Sign in to customize your interests

Name Your Search

Sign in to save your search

Lookup An Activity

My Saved Searches

My Saved Courses

Purchase access